Laurus Labs balance sheet

As of Sep 2026

Total assets: ₹11,514cr+22.3% on Sep 2025
Shareholders' equity: ₹6,181cr+25.3% on Sep 2025
Total debt: ₹2,490cr+15.8% on Sep 2025
Cash and investments: ₹24.5cr−50.9% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	3,847	3,873	3,668	3,446	3,016
	1,282	773	458	423	551
	0.0	0.0	0.0	178	133
	246	246	246	246	246
	17.2	18.4	19.3	19.0	12.9
	310	309	233	124	49.9
	46.4	44.3	48.7	47.4	49.4
	356	354	282	171	99.3
	24.3	2.4	6.9	3.0	20.4
	557	415	322	64.9	120
	6,330	5,682	5,003	4,552	4,199
	2,659	2,342	1,937	1,845	1,685
	2,242	2,155	2,007	1,663	1,580
	24.5	113	99.5	139	45.7
	4.3	1.0	44.7	2.7	2.8
	1.0	0.9	0.9	1.0	1.0
	4.6	3.2	5.9	8.8	16.3
	2,276	2,273	2,158	1,814	1,646
	249	214	238	175	131
	5,184	4,829	4,332	3,835	3,462
	11,514	10,511	9,336	8,387	7,660
Equity
	108	108	108	108	108
	5,953	5,192	4,365	4,003	3,930
	6,061	5,300	4,473	4,111	4,038
	120	131	130	4.6	11.1
	6,181	5,431	4,603	4,116	4,049
Liabilities
	553	611	646	798	761
	153	132	62.2	104	129
	706	743	708	903	890
	145	132	106	93.5	81.5
	26.2	29.4	31.9	57.0	82.5
	501	539	348	106	126
	1,379	1,444	1,193	1,159	1,179
	1,937	1,786	2,048	1,709	1,211
	1,301	1,252	958	1,051	711
	343	343	346	147	198
	3,581	3,381	3,352	2,907	2,119
	42.8	37.9	29.3	24.8	20.1
	170	54.3	57.2	36.2	65.0
	160	162	101	144	228
	3,954	3,635	3,540	3,112	2,432
	5,333	5,080	4,733	4,271	3,612
	11,514	10,511	9,336	8,387	7,660
Trade payables — MSME split
	42.4	51.2	27.8	—	—
	1,259	1,201	931	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LAURUSLABS₹2,181.90

Laurus Labs Ltd.

· Pharma & Health

₹ CrorePeersDIVISLAB GLAND MANKIND BIOCON ALKEM LUPIN FORTIS GLENMARKMcap ₹1.18L Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	3,016.0	3,446.4	3,668.5	3,873.2	3,846.6
+ Capital Work-in-Progress	550.8	422.8	458.4	773.3	1,282.4
+ Investment Property	133.4	178.3	0.0	0.0	0.0
+ Goodwill	246.3	246.3	246.3	246.3	246.3
+ Other Intangibles	12.9	19.0	19.3	18.4	17.2
+ Non-current Investments	49.9	124.0	233.3	309.3	310.0
+ Other Non-current Financial Assets	49.4	47.4	48.7	44.3	46.4
Non-current Financial Assets	99.3	171.4	281.9	353.5	356.4
+ Deferred Tax Assets	20.4	3.0	6.9	2.4	24.3
+ Other Non-current Assets	119.6	64.9	322.0	414.8	556.9
Total Non-current Assets	4,198.7	4,552.1	5,003.3	5,682.0	6,330.1
Current Assets
+ Inventories	1,684.8	1,845.4	1,936.5	2,342.2	2,659.1
+ Trade Receivables	1,580.4	1,662.9	2,007.2	2,155.0	2,241.5
+ Cash & Cash Equivalents	45.7	138.9	99.5	112.7	24.5
+ Other Bank Balances	2.8	2.7	44.7	1.0	4.3
+ Short-term Loans	1.0	1.0	0.9	0.9	1.0
+ Other Current Financial Assets	16.3	8.8	5.9	3.2	4.6
Current Financial Assets	1,646.2	1,814.3	2,158.2	2,272.9	2,275.9
+ Other Current Assets	130.7	175.2	237.6	214.2	248.7
Total Current Assets	3,461.7	3,835.0	4,332.3	4,829.2	5,183.6
Total Assets	7,660.4	8,387.0	9,335.6	10,511.2	11,513.7
Equity
+ Equity Share Capital	107.7	107.8	107.9	108.0	108.1
+ Other Equity / Reserves	3,929.8	4,003.2	4,364.7	5,192.1	5,952.5
Equity — Owners of Parent	4,037.5	4,111.0	4,472.6	5,300.1	6,060.6
+ Minority Interest	11.1	4.6	130.0	131.3	120.5
Total Equity	4,048.7	4,115.6	4,602.5	5,431.4	6,181.1
Liabilities
+ Borrowings — Non-current	761.4	798.2	645.6	611.3	553.3
+ Other Non-current Financial Liab	128.6	104.5	62.2	132.1	152.8
Non-current Financial Liabilities	890.1	902.7	707.8	743.5	706.2
+ Provisions — Non-current	81.5	93.5	106.1	132.1	145.0
+ Deferred Tax Liabilities	82.5	57.0	31.9	29.4	26.2
+ Other Non-current Liabilities	125.5	106.0	347.6	539.5	501.2
Non-current Liabilities	1,179.5	1,159.2	1,193.3	1,444.4	1,378.5
+ Borrowings — Current	1,210.6	1,708.8	2,047.5	1,786.2	1,936.6
+ Trade Payables	710.7	1,051.2	958.5	1,252.1	1,301.4
+ Other Current Financial Liab	198.0	147.0	346.1	343.1	343.2
Current Financial Liabilities	2,119.2	2,907.0	3,352.1	3,381.3	3,581.1
+ Provisions — Current	20.1	24.8	29.3	37.9	42.8
+ Current Tax Liabilities	65.0	36.2	57.2	54.3	170.4
+ Other Current Liabilities	228.0	144.3	101.1	162.0	159.7
Current Liabilities	2,432.3	3,112.3	3,539.7	3,635.4	3,954.1
Total Liabilities	3,611.7	4,271.5	4,733.1	5,079.8	5,332.6
Total Equity & Liabilities	7,660.4	8,387.0	9,335.6	10,511.2	11,513.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	27.8	51.2	42.4
+ Dues to Other Creditors — Current	—	—	930.7	1,200.9	1,258.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.